Rapid viral evolution and mutation pose continuous challenges to genomic surveillance and public health preparedness, while most existing computational approaches focus on analysing mutations only after they appear in real-world samples, limiting their ability to support early intervention. This paper presents the Quantum Bio-Mutation Foresight Simulator (Q-BMFS), a hybrid quantum–classical framework designed to explore and evaluate potential future mutation pathways before they naturally emerge. The proposed system combines quantum generative models with classical machine learning to simulate a large bio-mutation search space and assign probabilistic and risk-based interpretations to generated variants. Quantum Generative Adversarial Networks are employed to generate candidate mutation sequences, Quantum Circuit Born Machines are used to model mutation likelihood distributions, and Quantum Reservoir Computing captures temporal evolutionary behaviour, while a transformer-based classical model interprets long-range protein sequence dependencies. Experiments conducted using publicly available viral genome datasets and synthetically generated mutation samples demonstrate that Q-BMFS achieves improved predictive accuracy and more stable mutation likelihood modelling compared with classical baselines, and structural validation using RMSD analysis further indicates that the generated mutations preserve biologically plausible folding behaviour. These results suggest that quantum-enhanced foresight modelling can support proactive mutation analysis and may serve as a useful tool for future research in predictive virology and computational biology.
Rapid viral evolution and mutation pose continuous challenges to genomic surveillance and public health preparedness, while most existing computational approaches focus on analysing mutations only after they appear in real-world samples, limiting their ability to support early intervention. This paper presents the Quantum Bio-Mutation Foresight Simulator (Q-BMFS), a hybrid quantum–classical framework designed to explore and evaluate potential future mutation pathways before they naturally emerge. The proposed system combines quantum generative models with classical machine learning to simulate a large bio-mutation search space and assign probabilistic and risk-based interpretations to generated variants. Quantum Generative Adversarial Networks are employed to generate candidate mutation sequences, Quantum Circuit Born Machines are used to model mutation likelihood distributions, and Quantum Reservoir Computing captures temporal evolutionary behaviour, while a transformer-based classical model interprets long-range protein sequence dependencies. Experiments conducted using publicly available viral genome datasets and synthetically generated mutation samples demonstrate that Q-BMFS achieves improved predictive accuracy and more stable mutation likelihood modelling compared with classical baselines, and structural validation using RMSD analysis further indicates that the generated mutations preserve biologically plausible folding behaviour. These results suggest that quantum-enhanced foresight modelling can support proactive mutation analysis and may serve as a useful tool for future research in predictive virology and computational biology.
Accurate prediction of genetic disorders from DNA mutation data is a critical challenge in computational genomics due to complex mutation patterns and nonlinear genotype–phenotype relationships. This paper proposes a hybrid classical–quantum learning framework that integrates unified sequence graph feature encoding, transformer-based contextual modeling, dual-attention representation refinement, orangutan-based parameter optimization, and a variational quantum classifier for enhanced genetic disorder prediction. The proposed approach leverages hybrid classical–quantum learning to enhance discriminative feature learning in compact latent spaces. Experiments conducted on the Genetic Disorder Prediction Dataset demonstrate that the proposed framework achieves 94.10% accuracy, 93.60% precision, 93.40% F1-score, 92.00% Matthews correlation coefficient, and 96.70% AUC, outperforming existing machine learning and deep learning methods. Ablation studies confirm the contribution of each architectural component, while quantum circuit analysis identifies an optimal configuration of 8 qubits with a circuit depth of 4. Noise sensitivity and inference-time evaluations further indicate that the proposed model remains robust under realistic quantum noise conditions with only a marginal computational overhead. These results validate the effectiveness and practical feasibility of hybrid classical–quantum learning for genomic prediction tasks and highlight its potential for future quantum-assisted bioinformatics and precision medicine applications.
Accurate prediction of genetic disorders from DNA mutation data is a critical challenge in computational genomics due to complex mutation patterns and nonlinear genotype-phenotype relationships. This paper proposes a hybrid classical-quantum learning framework that integrates unified sequence graph feature encoding, transformer-based contextual modeling, dual-attention representation refinement, orangutan-based parameter optimization, and a variational quantum classifier for enhanced genetic disorder prediction. The proposed approach leverages hybrid classical-quantum learning to enhance discriminative feature learning in compact latent spaces. Experiments conducted on the Genetic Disorder Prediction Dataset demonstrate that the proposed framework achieves 94.10% accuracy, 93.60% precision, 93.40% F1-score, 92.00% Matthews correlation coefficient, and 96.70% AUC, outperforming existing machine learning and deep learning methods. Ablation studies confirm the contribution of each architectural component, while quantum circuit analysis identifies an optimal configuration of 8 qubits with a circuit depth of 4. Noise sensitivity and inference-time evaluations further indicate that the proposed model remains robust under realistic quantum noise conditions with only a marginal computational overhead. These results validate the effectiveness and practical feasibility of hybrid classical-quantum learning for genomic prediction tasks and highlight its potential for future quantum-assisted bioinformatics and precision medicine applications.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.
Quantum machine learning (QML) is a cross-disciplinary subject made up of two of the most exciting research areas: quantum computing and classical machine learning (ML), with ML and artificial intelligence (AI) being projected as the first fields that will be impacted by the rise of quantum machines. Quantum computers are being used today in drug discovery, material & molecular modelling and finance. In this work, we explore emerging research areas in the application of hybrid classical quantum machine learning (QML) in finance. We focus on hybrid classical-quantum models that have gained significant interest in the financial world for various applications. We utilise a real-world cryptocurrency dataset to train a quantum generative adversarial networks (qGAN), and implement the real-life NVIDIA stock price data on quantum LSTM (QLSTM), comparing its performance with classical Long Short Term Memory (LSTM) model. Additionally, we investigate the application of quantum circuit Born machine (QCBM) using a toy dataset for applications in finance. For the qGAN, we define quantum circuits for generators and showcase the potential for future quantum advantage in finance through QML, possibly in combination with QLSTM and QCBM. Our findings suggest that, while training classical data is more efficient on LSTM, the test predictions of QLSTM is slightly superior to its classical counterpart making it a promising candidate for financial forecasting and analysis for timeseries type data.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI\\\'s predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning's role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug- receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual\\\'s genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions.
Abstract Precision genomics and molecular discovery require generative systems that connect heterogeneous biological information with functional candidate design while controlling uncertainty, biological risk and computational expenditure. This study develops Quantum-Enhanced Genomic and Molecular Learning (QEGML), a conditional quantum–classical framework integrating a modality-aware encoder, a parameterized quantum latent distribution, a classical molecular or sequence decoder, and constrained candidate selection. The research combines a focused synthesis of relevant literature with mathematical derivation and transparent numerical scenario analysis. No new patient cohort, quantum-hardware experiment or biological assay is reported. Conditional likelihood and distributional regularization define training, while activity, off-target effects, toxicity, resource burden and predictive uncertainty determine selection. A four-candidate calculation shows that the highest assumed activity does not necessarily yield the preferred feasible candidate. With the declared weights, uncertainty adjustment changes the selected candidate from A to B, increasing the evaluated risk-adjusted utility from 0.650 to 0.715. The ranking crossover occurs at a risk-aversion coefficient of 0.1875. Independent-shot calculations further show that reducing the worst-case standard error of a binary measurement from 0.050 to 0.0125 requires increasing the shot count from 100 to 1,600. A published molecular-discovery example is considered separately from these calculations. Comparative analysis specifies matched classical controls, noise ablations and cost-aware evaluation without assigning unmeasured performance gains to the quantum component. The contribution is an auditable framework linking generative representation, decision reliability and experimental accountability. Its practical value remains conditional on prospective biological validation and demonstrable improvement over strong classical alternatives. Keywords: quantum generative learning; precision genomics; multi-omics integration; conditional generation; variational quantum circuits; quantum Born machines; molecular discovery; genomic language models; constrained optimization; uncertainty quantification; finite-shot sampling; model calibration; experimental validation; computational benchmarking.